Suppr超能文献

多中心起源肝细胞癌患者的预后。

The prognosis of patients with hepatocellular carcinoma of multicentric origin.

作者信息

Okusaka T, Okada S, Nose H, Ishii H, Nakasuka H, Nakayama H, Nagahama H, Yoshimori M, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S

机构信息

Department of Internal Medicine1 and Surgery, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Hepatogastroenterology. 1996 Jul-Aug;43(10):919-25.

PMID:8884314
Abstract

BACKGROUND/AIMS: The characteristics of patients with multicentric hepatocellular carcinoma (HCC) differ from those of patients with intrahepatic metastatic HCC. However, there are few reports regarding the long-term results in patients with HCC of multicentric occurrence. The purpose of this study was to clarify the prognosis of a group of patients with multicentric HCCs.

MATERIALS AND METHODS

We evaluated the outcome in 28 patients with multiple hepatocellular carcinoma (HCC) suggestive of multicentric occurrence, all of whom underwent hepatic resection. The disease-free survival, recurrence pattern and survival were analyzed in the two subgroups of 12 patients with single advanced HCC (AdHCC) nodule and an early HCC (eHCC) or early advanced HCC (eAdHCC) nodule [Group A] and 16 patients with two AdHCC lesions [Group B]. These data were also compared with those of 58 patients with solitary AdHCC [Group C].

RESULTS

Both the disease-free survival and survival periods for Groups A and C were significantly longer than those for Group B, while no significant difference was seen between Group A and C. No significant differences among the three groups were recognized in the incidence of various types of recurrence pattern.

CONCLUSIONS

The long-term results in patients with multicentric HCC apparently vary depending on the pathological condition at the time of operation. Among patients with multicentric HCC, those with AdHCC combined with an eHCC or eAdHCC are likely to show improved prognosis as a result of hepatic resection.

摘要

背景/目的:多中心肝细胞癌(HCC)患者的特征与肝内转移性HCC患者不同。然而,关于多中心发生的HCC患者的长期结果的报道较少。本研究的目的是阐明一组多中心HCC患者的预后。

材料与方法

我们评估了28例提示多中心发生的多发性肝细胞癌(HCC)患者的结局,所有患者均接受了肝切除术。对12例单一晚期HCC(AdHCC)结节合并早期HCC(eHCC)或早期晚期HCC(eAdHCC)结节的患者[ A组]和16例有两个AdHCC病灶的患者[ B组]的两个亚组的无病生存期、复发模式和生存率进行了分析。这些数据还与58例孤立性AdHCC患者[ C组]的数据进行了比较。

结果

A组和C组的无病生存期和生存期均明显长于B组,而A组和C组之间未见明显差异。三组之间在各种复发模式的发生率方面未发现明显差异。

结论

多中心HCC患者的长期结果显然因手术时的病理状况而异。在多中心HCC患者中,AdHCC合并eHCC或eAdHCC的患者可能因肝切除而预后改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验